欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
SK/H/0143/002
药品名称
Metypred 16 mg
活性成分
methylprednisolone 16.0 mg
剂型
Tablet
上市许可持有人
Orion Corporation Orionintie 1 FI-02200 Espoo Finland
参考成员国 - 产品名称
Slovakia (SK)
Metypred 16 mg
互认成员国 - 产品名称
Lithuania (LT)
Metypred 16 mg tabletės
Czechia (CZ)
Denmark (DK)
Sweden (SE)
Norway (NO)
许可日期
2011/10/18
最近更新日期
2024/07/21
药物ATC编码
H02AB04 methylprednisolone
申请类型
TypeLevel1：
[not specified]
TypeLevel2：
[not specified]
TypeLevel3：
[not specified]
TypeLevel4：
[not specified]
TypeLevel5：
[not specified]
附件文件下载
Final Product Information
|
Metypred 4 16mg tabl MRP PIL 111012019clean
Date of last change:2019/01/11
Final Product Information
|
EU Metypred 4 16mg tabl MRP SPC 11012019clean
Date of last change:2019/01/11
Final PL
|
Metypred 4 16mg tabl MRP PIL 090818clean
Date of last change:2018/09/20
Final PL
|
Metypred 4 16mg tabl MRP PIL 090818changes
Date of last change:2018/09/20
Final SPC
|
EU Metypred 4 16mg tabl MRP SPC 010618clean
Date of last change:2018/09/20
Final SPC
|
EU Metypred 4 16mg tabl MRP SPC 010618changes
Date of last change:2018/09/20
Final Labelling
|
Methylprednisolone 16 mg tabl MRP label 010618changes
Date of last change:2018/09/20
Final Labelling
|
Methylprednisolone 4 mg tabl MRP Label 010618changes
Date of last change:2018/09/20
Final Labelling
|
Methylprednisolone 4 mg tabl MRP Label 010618cleans
Date of last change:2018/09/20
Final Labelling
|
Methylprednisolone 16 mg tabl MRP label 010618clean
Date of last change:2018/09/20
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase